Skip to main content
. 2022 Mar 21;41(Suppl 1):1–178. doi: 10.1007/s12664-021-01234-z
Evaluated Therapy Baseline (Mean + SD) At 24 wks (Mean + SD) % Change p-value (Stat Sig.)
CAP (dB/m) LSM (Kpa) CAP (dB/m) LSM(Kpa) CAP LSM CAP LSM
Lifestyle intervention (n=35) 273.1 + 61.9 16.9 + 14.9 266.1 + 53.5 16.1 + 14.3 -2.6 % -4.9 % >0.05 (NS)

>0.05

(NS)

Vit E (n=80) 305.3 + 44.6 7.3 + 4.5 287.1 + 37.5 6.7 + 6.5 -5.9 % -8.3% <0.001 (HS) >0.05 (NS)
Saroglitazar (n=68) 312.8 + 43.3 12.3 + 7.9 278.8 + 49.3 9.8 + 5.6 -10.9 % -20.2 % <0.001 (HS) <0.001 (HS)